Paras Healthcare Sets IPO Price Band at ₹660-₹693, Opening October 21
Paras Healthcare has announced its initial public offering (IPO) priced between Rs 660 and Rs 693 per equity share, aiming to raise Rs 1,450 crore. The offering is structured as a fresh issue of 72.15 lakh shares worth Rs 500 crore, accompanied by an offer for sale (OFS) of 1.37 crore shares valued at Rs 950 crore. The subscription window will open from October 21 to October 23, 2026, with shares expected to be listed on the NSE and BSE on October 28, 2026. Retail investors are required to purchase a minimum of 21 shares, constituting an investment of approximately Rs 14,553 at the upper price band.
Current grey market sentiment for Paras Healthcare indicates cautious optimism, with early indications suggesting a premium for the IPO shares. This sentiment reflects an overall positive outlook towards healthcare sector investments amidst rising consumer demand for quality healthcare services. While specific grey market pricing has not been detailed, the general atmosphere suggests that retail and institutional investors are closely watching the subscription trends as the opening date approaches.
This IPO is significant for Indian investors, especially as it taps into the growing healthcare sector, which is poised for expansion. Investors should consider the company’s plans for future growth, including its commitment to increase bed capacity significantly by 2028. Moreover, the dual approach of fresh equity along with OFS provides both liquidity and capital backing for strategic initiatives, making it a noteworthy opportunity in the current IPO landscape.
• WEALTHOVA INSIGHTS
Investors should carefully assess the financial health and growth strategy of Paras Healthcare as it prepares for its IPO. With an expanding network and substantial investment in future capacity, this offering could represent a strong opportunity in the healthcare space, providing avenues for potential growth in retail portfolios.
Disclaimer: Market insights and analyses on Wealthova are strictly for educational and informational purposes and do not constitute financial or investment advice. Please consult a SEBI-registered financial advisor before making investment decisions.
Source: The Economic Times
(Expert Note: This report was prepared by the Wealthova IPO team.)

